AcceLINX appoints new leader
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
Warsaw-based AcceLINX, a musculoskeletal health business accelerator launched by OrthoWorx, has appointed Mark Schindel to lead general operations of the company. Schindel will succeed AcceLINX co-founder David Anderson, who led its overall development and operations since its launch in 2017.
Schindel has served as a commercial affairs consultant for AcceLINX since 2021.
“Both the AcceLINX Board and I are extremely excited for Mark to assume his new set of responsibilities and elated to have someone with all the varied orthopedic and entrepreneurial experience that he brings into this role,” OrthoWorx CEO Bob Vitoux said. “Mark’s successful track record of having been instrumental in his role as Co-Founder and CEO at Owl Manor Medical during the company’s start-up, development, and eventual sale, along with his broad range of medical device experience and present connectivity, will be invaluable in his new role at AcceLINX serving our clients and leading us into the future.”
In his new role, Schindel will assume leadership for day-to-day commercial and general management activities, as well as oversight of the organization’s subject matter expert consultant group.
“I look forward to working with the AcceLINX team and building on its history of value creation for medical device technologies and companies,” said Schindel. “I also am anxious to work with Bob, OrthoWorx, and the esteemed and newly reconstructed AcceLINX board to advance the technologies, services, and products offered across the musculoskeletal industry.”
Previously, Schindel served in various leadership positions at corporations including Roche, Biomet, Zimmer, and Tornier.